BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22106917)

  • 1. Cytomegalovirus colitis and viremia from mycophenolate mofetil monotherapy in birdshot chorioretinopathy.
    Pantanelli SM; Khalifa YM
    Ocul Immunol Inflamm; 2011 Dec; 19(6):450-2. PubMed ID: 22106917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.
    Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kisilisik AT; Trofe J; Alloway RR; Gaber LW; Gaber AO
    Transpl Infect Dis; 2001 Mar; 3(1):8-15. PubMed ID: 11429034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil.
    Brum S; Nolasco F; Sousa J; Ferreira A; Possante M; Pinto JR; Barroso E; Santos JR
    Transplant Proc; 2008 Apr; 40(3):752-4. PubMed ID: 18455007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus colitis during mycophenolate mofetil therapy for Wegener's granulomatosis.
    Woywodt A; Choi M; Schneider W; Kettritz R; Göbel U
    Am J Nephrol; 2000; 20(6):468-72. PubMed ID: 11146314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful conversion to everolimus after cytomegalovirus infection in a heart transplant recipient.
    Imamura T; Shiga T; Kinugawa K; Kato N; Endo M; Inaba T; Maki H; Hatano M; Yao A; Hirata Y; Nagai R
    Int Heart J; 2012; 53(3):199-201. PubMed ID: 22790690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus colitis in a CMV-seropositive renal transplant recipient on triple drug therapy (including mycophenolate).
    Smak Gregoor PJ; van Gelder T; Abraham Tanis A; Chadha-Ajwani S; Klaassen RJ; Weimar W
    Nephrol Dial Transplant; 1997 Dec; 12(12):2766-7. PubMed ID: 9430894
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus.
    Gruber SA; Garnick J; Morawski K; Sillix DH; West MS; Granger DK; El-Amm JM; Alangaden GJ; Chandrasekar P; Haririan A
    Clin Transplant; 2005 Apr; 19(2):273-8. PubMed ID: 15740567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic acid in the treatment of birdshot chorioretinopathy: long-term follow-up.
    Doycheva D; Jägle H; Zierhut M; Deuter C; Blumenstock G; Schiefer U; Stingl K; Januschowski K; Voykov B; Stuebiger N
    Br J Ophthalmol; 2015 Jan; 99(1):87-91. PubMed ID: 25061107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valganciclovir-induced leukopenia in liver transplant recipients: influence of concomitant use of mycophenolate mofetil.
    Molina Perez E; Fernández Castroagudín J; Seijo Ríos S; Mera Calviño J; Tomé Martínez de Rituerto S; Otero Antón E; Bustamante Montalvo M; Varo Perez E
    Transplant Proc; 2009 Apr; 41(3):1047-9. PubMed ID: 19376423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction.
    Giral M; Nguyen JM; Daguin P; Hourmant M; Cantarovich D; Dantal J; Blancho G; Josien R; Ancelet D; Soulillou JP
    J Am Soc Nephrol; 2001 Aug; 12(8):1758-1763. PubMed ID: 11461950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F; Serón D; Morales JM; Cruzado JM; Gil-Vernet S; Pérez JL; Fulladosa X; Andrés A; Grinyó JM
    Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cytomegalovirus infectious colitis complicating Crohn's disease successfully treated with oral valganciclovir.
    Subramanian V; Finlayson C; Harrison T; Rice P; Pollok R
    J Crohns Colitis; 2010 Jun; 4(2):199-202. PubMed ID: 21122506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hickam's dictum in a patient with diarrhea.
    Feuerstein JD; Najarian R; Cheifetz AS
    Gastroenterology; 2013 Nov; 145(5):942, 1165. PubMed ID: 24070726
    [No Abstract]   [Full Text] [Related]  

  • 14. [Leukopenia in kidney transplantation resulting from the interaction between mycophenolate mofetil and valganciclovir].
    Izquierdo MJ; Rodrigo E; de Cos MA; Arias M
    Nefrologia; 2007; 27(2):232-3. PubMed ID: 17564576
    [No Abstract]   [Full Text] [Related]  

  • 15. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.
    Sarmiento JM; Munn SR; Paya CV; Velosa JA; Nguyen JH
    Clin Transplant; 1998 Oct; 12(5):371-4. PubMed ID: 9787943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation.
    ter Meulen CG; Wetzels JF; Hilbrands LB
    Nephrol Dial Transplant; 2000 May; 15(5):711-4. PubMed ID: 10809816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient.
    Bienvenu B; Thervet E; Bedrossian J; Scieux C; Mazeron MC; Thouvenot D; Legendre C
    Transplantation; 2000 Jan; 69(1):182-4. PubMed ID: 10653401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up.
    Cervantes-Castañeda RA; Gonzalez-Gonzalez LA; Cordero-Coma M; Yilmaz T; Foster CS
    Br J Ophthalmol; 2013 May; 97(5):637-43. PubMed ID: 23435191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV
    Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
    Bataille S; Moal V; Gaudart J; Indreies M; Purgus R; Dussol B; Zandotti C; Berland Y; Vacher-Coponat H
    Transpl Infect Dis; 2010 Dec; 12(6):480-8. PubMed ID: 20629971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.